OpenAI’s ad revenue forecast is on pace to miss its 2030 target by 90%, according to Emarketer. The post The latest ...

Netherlands-based QuiX Quantum has delivered Carina, the world's first universal photonic quantum computer designed for ...

AI is a powerful brainstorming tool when used correctly. Here's how to write better prompts and refine ideas more effectively ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1. Mary Abrahamson hopes to be one of them. The rural ...

Share on Pinterest An estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials announced the launch ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through the end of ...

A program designed to protect domestic violence victims from their offenders during the criminal court process is expected to run out of money in August. The Electronic Monitoring with Victim ...

Hello, my name is Julie Devoll, editor of special projects and webinars for Harvard Business Review. I recently had the pleasure of attending Zero Trust World and sitting down with Ryan Bowman, vice ...

For years, social media giants controlled what users saw in their feeds. While people could follow accounts, like posts or hide content they didn’t enjoy, recommendation algorithms controlled what was ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Weight loss drugs ...

Implementation sits outside Part D, with Humana handling PA, adjudication, and reimbursement; manufacturers provide a $245 net price for Wegovy, Zepbound, and orforglipron. Eligibility requires PA and ...